Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer

Finding prognostic biomarkers with high accuracy in patients with pancreatic cancer (PC) remains a challenging problem. To improve the prediction of survival and to investigate the relevance of quantitative imaging biomarkers (QIB) we combined QIB with established clinical parameters. In this retros...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leonie Gebauer, Jan H. Moltz, Alexander Mühlberg, Julian W. Holch, Thomas Huber, Johanna Enke, Nils Jäger, Michael Haas, Stephan Kruger, Stefan Boeck, Michael Sühling, Alexander Katzmann, Horst Hahn, Wolfgang G. Kunz, Volker Heinemann, Dominik Nörenberg, Stefan Maurus
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/cd6bd218ec444ae08b5c40194c7e5b54
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd6bd218ec444ae08b5c40194c7e5b54
record_format dspace
spelling oai:doaj.org-article:cd6bd218ec444ae08b5c40194c7e5b542021-11-25T17:03:22ZQuantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer10.3390/cancers132257322072-6694https://doaj.org/article/cd6bd218ec444ae08b5c40194c7e5b542021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5732https://doaj.org/toc/2072-6694Finding prognostic biomarkers with high accuracy in patients with pancreatic cancer (PC) remains a challenging problem. To improve the prediction of survival and to investigate the relevance of quantitative imaging biomarkers (QIB) we combined QIB with established clinical parameters. In this retrospective study a total of 75 patients with metastatic PC and liver metastases were analyzed. Segmentations of whole liver tumor burden (WLTB) from baseline contrast-enhanced CT images were used to derive QIBs. The benefits of QIBs in multivariable Cox models were analyzed in comparison with two clinical prognostic models from the literature. To discriminate survival, the two clinical models had concordance indices of 0.61 and 0.62 in a statistical setting. Combined clinical and imaging-based models achieved concordance indices of 0.74 and 0.70 with WLTB volume, tumor burden score (TBS), and bilobar disease being the three WLTB parameters that were kept by backward elimination. These combined clinical and imaging-based models have significantly higher predictive performance in discriminating survival than the underlying clinical models alone (<i>p</i> < 0.003). Radiomics and geometric WLTB analysis of patients with metastatic PC with liver metastases enhances the modeling of survival compared with models based on clinical parameters alone.Leonie GebauerJan H. MoltzAlexander MühlbergJulian W. HolchThomas HuberJohanna EnkeNils JägerMichael HaasStephan KrugerStefan BoeckMichael SühlingAlexander KatzmannHorst HahnWolfgang G. KunzVolker HeinemannDominik NörenbergStefan MaurusMDPI AGarticlecomputed tomographyradiomicsquantitative imaging biomarkerwhole liver tumor burdenspatial analysismetastatic pancreatic cancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5732, p 5732 (2021)
institution DOAJ
collection DOAJ
language EN
topic computed tomography
radiomics
quantitative imaging biomarker
whole liver tumor burden
spatial analysis
metastatic pancreatic cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle computed tomography
radiomics
quantitative imaging biomarker
whole liver tumor burden
spatial analysis
metastatic pancreatic cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Leonie Gebauer
Jan H. Moltz
Alexander Mühlberg
Julian W. Holch
Thomas Huber
Johanna Enke
Nils Jäger
Michael Haas
Stephan Kruger
Stefan Boeck
Michael Sühling
Alexander Katzmann
Horst Hahn
Wolfgang G. Kunz
Volker Heinemann
Dominik Nörenberg
Stefan Maurus
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
description Finding prognostic biomarkers with high accuracy in patients with pancreatic cancer (PC) remains a challenging problem. To improve the prediction of survival and to investigate the relevance of quantitative imaging biomarkers (QIB) we combined QIB with established clinical parameters. In this retrospective study a total of 75 patients with metastatic PC and liver metastases were analyzed. Segmentations of whole liver tumor burden (WLTB) from baseline contrast-enhanced CT images were used to derive QIBs. The benefits of QIBs in multivariable Cox models were analyzed in comparison with two clinical prognostic models from the literature. To discriminate survival, the two clinical models had concordance indices of 0.61 and 0.62 in a statistical setting. Combined clinical and imaging-based models achieved concordance indices of 0.74 and 0.70 with WLTB volume, tumor burden score (TBS), and bilobar disease being the three WLTB parameters that were kept by backward elimination. These combined clinical and imaging-based models have significantly higher predictive performance in discriminating survival than the underlying clinical models alone (<i>p</i> < 0.003). Radiomics and geometric WLTB analysis of patients with metastatic PC with liver metastases enhances the modeling of survival compared with models based on clinical parameters alone.
format article
author Leonie Gebauer
Jan H. Moltz
Alexander Mühlberg
Julian W. Holch
Thomas Huber
Johanna Enke
Nils Jäger
Michael Haas
Stephan Kruger
Stefan Boeck
Michael Sühling
Alexander Katzmann
Horst Hahn
Wolfgang G. Kunz
Volker Heinemann
Dominik Nörenberg
Stefan Maurus
author_facet Leonie Gebauer
Jan H. Moltz
Alexander Mühlberg
Julian W. Holch
Thomas Huber
Johanna Enke
Nils Jäger
Michael Haas
Stephan Kruger
Stefan Boeck
Michael Sühling
Alexander Katzmann
Horst Hahn
Wolfgang G. Kunz
Volker Heinemann
Dominik Nörenberg
Stefan Maurus
author_sort Leonie Gebauer
title Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
title_short Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
title_full Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
title_fullStr Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
title_full_unstemmed Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
title_sort quantitative imaging biomarkers of the whole liver tumor burden improve survival prediction in metastatic pancreatic cancer
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/cd6bd218ec444ae08b5c40194c7e5b54
work_keys_str_mv AT leoniegebauer quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT janhmoltz quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT alexandermuhlberg quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT julianwholch quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT thomashuber quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT johannaenke quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT nilsjager quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT michaelhaas quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT stephankruger quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT stefanboeck quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT michaelsuhling quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT alexanderkatzmann quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT horsthahn quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT wolfganggkunz quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT volkerheinemann quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT dominiknorenberg quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
AT stefanmaurus quantitativeimagingbiomarkersofthewholelivertumorburdenimprovesurvivalpredictioninmetastaticpancreaticcancer
_version_ 1718412804663279616